In the present study, to explore how PD-L1 expression is associated with transcriptomic reprogramming and drug resistance, we have assessed the transcriptomic landscape of melanoma cell lines with constitutively high levels of PD-L1 expression (PD-L1CON). Here, CD274 is linked to melanoma.